COVID-19 Clinical Trials in Boston, Massachusetts

6 studies are recruiting for covid-19 in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

   This phase 1 randomized, open-label, dose-escalation clinical trial evaluates the safety and immunogenicity of OCU500, a ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine, in healthy adults aged 18-64 who previously completed a primary COVID-19 vaccination series and at least one booster. The study e…

   Stage

   Phase 1

   Ages

   18 to 64

   Site

   Brigham and Women's Hospital, Boston, Massachusetts

   Locations

   6 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07536308 on ClinicalTrials.gov

2. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

   This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

   Stage

   Phase 3

   Ages

   Any age

   Site

   Brigham and Women's Hospital, Boston, Massachusetts

   Locations

   28 in total

   Run by

   Ansun Biopharma, Inc.

   See if you can join NCT03808922 on ClinicalTrials.gov

3. Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

   The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertional malaise, effect of breathlessness on daily activities, post-COVID-19 symptom burden, and biomar…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Brigham and Women's Hospital, Boston, Massachusetts

   Locations

   17 in total

   Run by

   Wes Ely

   See if you can join NCT06631287 on ClinicalTrials.gov

4. Positron Emission Tomography (PET) Imaging of Thrombosis

   The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invas…

   Stage

   Phase 1

   Ages

   18 to 85

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Run by

   Massachusetts General Hospital

   See if you can join NCT03830320 on ClinicalTrials.gov

5. Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

   This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the ob…

   Stage

   Not phased

   Ages

   18 to 50

   Site

   Boston University School of Public Health, Global Health, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Boston University

   See if you can join NCT06168019 on ClinicalTrials.gov

6. EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

   The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/r…

   Stage

   Phase 3

   Ages

   0 to 17

   Site

   Boston Medical Center, Boston, Massachusetts

   Locations

   73 in total

   Run by

   Pfizer

   See if you can join NCT05261139 on ClinicalTrials.gov